NewsBenzingaZoetis高管称,第三季度犬类兽医就诊量下降约5%,其中与瘙痒相关的就诊量下降约3%;来自仿制版Convenia和Cerenia竞争带来的销量下滑已放缓至自这些仿制药在第一季度进入市场以来的最低水平 Zoetis高管称,第三季度犬类兽医就诊量下降约5%,其中与瘙痒相关的就诊量下降约3%;来自仿制版Convenia和Cerenia竞争带来的销量下滑已放缓至自这些仿制药在第一季度进入市场以来的最低水平 Benzinga 2026.11.05 14:00 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?